US Merck Products

(suvorexant) 5, 10, 15, 20 mg tablets, for oral use, C-IV

(sugammadex) injection 100 mg/mL (equivalent to 108.8 mg/mL sugammadex sodium), for intravenous use

(fidaxomicin) tablets 200 mg | oral suspension 200 mg/5 ml

(doravirine 100 mg/islatravir 0.25 mg) tablets

ISENTRESS® (raltegravir 400 mg) film-coated tablets, for oral use; chewable tablets, for oral use; oral suspension and ISENTRESS® HD (raltegravir 600 mg) film-coated tablets, for oral use

JANUMET® (sitagliptin and metformin HCI) 50/500 mg, 50/1000 mg tablets and JANUMET® XR (sitagliptin and metformin HCI extended-release) 50/500 mg, 50/1000 mg, 100/1000 mg tablets

(sitagliptin) 25 mg, 50 mg, 100 mg tablets

PIFELTRO® (doravirine 100 mg) tablets and DELSTRIGO® (doravirine 100 mg/lamivudine 300 mg/tenofovir disoproxil fumarate 300 mg) tablets

PREVYMIS® (letermovir) 240 mg, 480 mg tablets / Injection 20 mg/mL / Oral pellets 20 mg, 120 mg per packet

(imipenem, cilastatin, and relebactam) for injection 1.25 g

(ertugliflozin and metformin HCI) 2.5 mg/500 mg, 2.5 mg/1000 mg, 7.5 mg/500 mg, 7.5 mg/1000 mg tablets

(tedizolid phosphate) 200 mg injection, for intravenous use; 200 mg tablet, for oral use

(ertugliflozin) 5 mg, 15 mg tablets

(ertugliflozin and sitagliptin) 5 mg/100 mg, 15 mg/100 mg tablets

(vericiguat) tablets 2.5 mg, 5 mg, 10 mg

(belzutifan) 40 mg tablets

(sotatercept-csrk) for injection 45 mg, 60 mg

(ceftolozane and tazobactam) for injection (1.5 g), for intravenous use

(bezlotoxumab) injection 25 mg/mL